Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aimei Health Technology CoAFJK +0.68%16 Return-on-Tangible-Asset is 1.48% as of Mar. 2026, which is 51% below its 10-year median of 3.01. GuruFocus rates AFJK with a GF Scoreâ„¢ of 16/100. The stock has 1 warning sign investors should review. Among 557 Diversified Financial Services companies, Aimei Health Technology Co ranks better than 81.87% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Aimei Health Technology Co's annualizedNet Income for the quarter that ended in Mar. 2026 was $0.18 Mil. Aimei Health Technology Co's average total tangible assets for the quarter that ended in Mar. 2026 was $12.20 Mil. Therefore, Aimei Health Technology Co's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 1.48%.
The historical rank and industry rank for Aimei Health Technology Co's Return-on-Tangible-Asset or its related term are showing as below:
AFJK'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 2.47 Med: 3.01 Max: 3.54
Current: 2.91
During the past 3 years, Aimei Health Technology Co's highest Return-on-Tangible-Asset was 3.54%. The lowest was 2.47%. And the median was 3.01%.
AFJK's Return-on-Tangible-Asset is ranked better than 81.87% of 557
companies
in the Diversified Financial Services industry
Industry Median: 0.72
vs AFJK: 2.91
Aimei Health Technology Co (NAS:AFJK) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companyÂ’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companyÂ’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Aimei Health Technology Co Return-on-Tangible-Asset Related Terms
Aimei Health Technology Co Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aimei Health Technology Co Return-on-Tangible-Asset Chart
AFJK vs BRRN, RDAC, MSSAF: Return-on-Tangible-Asset Comparison
For the Shell Companies subindustry, Aimei Health Technology Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aimei Health Technology Co Return-on-Tangible-Asset vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Aimei Health Technology Co's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Aimei Health Technology Co's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 1.48% mean?
Aimei Health Technology Co (AFJK) has a Return-on-Tangible-Asset of 1.48% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Aimei Health Technology Co and its competitors. This is 51% below median its historical median of 3.01. Over the past decade, Aimei Health Technology Co's Return-on-Tangible-Asset has ranged from 2.47 to 3.54. According to the industry distribution chart, Aimei Health Technology Co ranks #101 out of 557 companies in the Diversified Financial Services industry, placing it in the top 18.1%.
Is Aimei Health Technology Co's Return-on-Tangible-Asset too high?
Aimei Health Technology Co's current Return-on-Tangible-Asset of 1.48% is 51% below median its 10-year median of 3.01. Over the past 10 years, this metric has ranged from a low of 2.47 to a high of 3.54. The Diversified Financial Services industry median Return-on-Tangible-Asset is 0.72. Aimei Health Technology Co's value of 1.48% is 105.6% above this industry median. Based on the distribution chart, Aimei Health Technology Co ranks #101 out of 557 companies in the Diversified Financial Services industry, which is in the top quartile — a strong position relative to peers. Overall, Aimei Health Technology Co has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Aimei Health Technology Co's Return-on-Tangible-Asset compare to BRRN and RDAC?
According to the Diversified Financial Services industry distribution chart, Aimei Health Technology Co ranks #101 out of 557 companies for Return-on-Tangible-Asset. This places Aimei Health Technology Co in the top 18% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 0.72. Aimei Health Technology Co's value of 1.48% is 105.6% above this benchmark. Historically, Aimei Health Technology Co's own Return-on-Tangible-Asset has ranged from 2.47 to 3.54 over the past decade. While the company's 10-year median is 3.01 vs. the industry median of 0.72, Aimei Health Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Diversified Financial Services company?
The median Return-on-Tangible-Asset among Diversified Financial Services companies is 0.72, based on 557 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aimei Health Technology Co's current Return-on-Tangible-Asset of 1.48% is 105.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Aimei Health Technology Co and its competitors. For the Diversified Financial Services industry, the median Return-on-Tangible-Asset is 0.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aimei Health Technology Co's current Return-on-Tangible-Asset is 1.48%, which is 51% below median its own 10-year median of 3.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aimei Health Technology Co stock overvalued right now?
Aimei Health Technology Co (AFJK) has a current Return-on-Tangible-Asset of 1.48%. The current Return-on-Tangible-Asset is 1.48%, which is 51% below median its 10-year median of 3.01 and 105.6% above the Diversified Financial Services industry median of 0.72. Aimei Health Technology Co's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Aimei Health Technology Co (AFJK), the current Return-on-Tangible-Asset is 1.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AFJK has been successfully added to your 
